1. Nangalia, J, Massie, C E, Baxter, E J, Campbell, P J, Green, A R. 2013. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. In The New England journal of medicine, 369, 2391-2405. doi:10.1056/NEJMoa1312542. https://pubmed.ncbi.nlm.nih.gov/24325359/
2. Klampfl, Thorsten, Gisslinger, Heinz, Harutyunyan, Ashot S, Cazzola, Mario, Kralovics, Robert. 2013. Somatic mutations of calreticulin in myeloproliferative neoplasms. In The New England journal of medicine, 369, 2379-90. doi:10.1056/NEJMoa1311347. https://pubmed.ncbi.nlm.nih.gov/24325356/
3. Liu, Xiaoxu, Xie, Peiling, Hao, Na, He, Jianjun, Zhang, Huimin. . HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2109144118. https://pubmed.ncbi.nlm.nih.gov/34706936/